Search research articles
Contact Us
Filters
Showing results (211-220 of 528) with videos related to
Page
of 53
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
September 5, 2006
Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer
Michael L Maitland, Rebecca Wilcox, D Kyle Hogarth, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
<i>STK11</i> as an Emerging Biomarker in Non-Small Cell Lung Cancer
Amit A Kulkarni, Adam Rock, Matthew Lee, et al.
Cancer Research
|
April 19, 2007
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts
Neelu Puri, Andrey Khramtsov, Salman Ahmed, et al.
Cancer Science
|
January 12, 2017
TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer
Jae-Hyun Park, Hiroyuki Inoue, Taigo Kato, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
December 5, 2024
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview
Pankaj Garg, Gargi Singhal, Siddhika Pareek, et al.
Oncotarget
|
April 12, 2014
Molecular pathways and therapeutic targets in lung cancer
Emma Shtivelman, Thomas Hensing, George R Simon, et al.
Plos One
|
March 26, 2014
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer
Frances E Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, et al.
Targeted Oncology
|
September 13, 2012
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma
Andres Morales La Madrid, Andres Morales La Madrid, Nicholas Campbell, et al.
Scientific Reports
|
September 30, 2024
Comprehensive investigation of long non-coding RNA HOTAIR polymorphisms and cancer risk: a current meta-analysis encompassing 96,458 participants
B Madhu Krishna, Pankaj Garg, Sravani Ramisetty, et al.
Biomedicines
|
December 19, 2020
<i>Salmonella</i>-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy
Nancy D Ebelt, Edith Zuniga, Monica Marzagalli, et al.
Page
of 53
Search research articles
Search
Showing results (211-220 of 528) with videos related to
Sort By:
Page
of 53
Lung Cancer (Amsterdam, Netherlands)
|
September 5, 2006
Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer
Michael L Maitland, Rebecca Wilcox, D Kyle Hogarth, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
<i>STK11</i> as an Emerging Biomarker in Non-Small Cell Lung Cancer
Amit A Kulkarni, Adam Rock, Matthew Lee, et al.
Cancer Research
|
April 19, 2007
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts
Neelu Puri, Andrey Khramtsov, Salman Ahmed, et al.
Cancer Science
|
January 12, 2017
TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer
Jae-Hyun Park, Hiroyuki Inoue, Taigo Kato, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
December 5, 2024
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview
Pankaj Garg, Gargi Singhal, Siddhika Pareek, et al.
Oncotarget
|
April 12, 2014
Molecular pathways and therapeutic targets in lung cancer
Emma Shtivelman, Thomas Hensing, George R Simon, et al.
Plos One
|
March 26, 2014
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer
Frances E Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, et al.
Targeted Oncology
|
September 13, 2012
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma
Andres Morales La Madrid, Andres Morales La Madrid, Nicholas Campbell, et al.
Scientific Reports
|
September 30, 2024
Comprehensive investigation of long non-coding RNA HOTAIR polymorphisms and cancer risk: a current meta-analysis encompassing 96,458 participants
B Madhu Krishna, Pankaj Garg, Sravani Ramisetty, et al.
Biomedicines
|
December 19, 2020
<i>Salmonella</i>-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy
Nancy D Ebelt, Edith Zuniga, Monica Marzagalli, et al.
Page
of 53